Today: 9 April 2026
Mortgage rates today stick near 6.1% as bond yields hold; homebuilder stocks lift premarket
5 February 2026
1 min read

Mortgage rates today stick near 6.1% as bond yields hold; homebuilder stocks lift premarket

NEW YORK, Feb 5, 2026, 06:37 (EST) — Premarket

  • On Thursday, the average 30-year fixed conforming mortgage rate held steady at 6.096%, showing little movement from the previous day.
  • MBA data revealed mortgage applications declined last week, as winter weather weighed on purchase demand.
  • Shares tied to housing climbed ahead of the open, even as mortgage lender Rocket dipped.

U.S. mortgage rates held steady early Thursday. The daily average for a 30-year fixed conforming loan ticked up just 0.01 percentage point to 6.096% from the day before. Fortune

That’s crucial since borrowing costs remain elevated, sidelining many potential buyers and those looking to refinance. The market’s focus is locked on whether rates can dip below 6% and hold there long enough to revive activity in the spring selling season.

Mortgage rates usually track longer-term Treasury yields, which set benchmarks for many consumer loans. The most recent official figure showed the U.S. 10-year Treasury yield at 4.28%. FRED

Housing-related stocks edged higher ahead of the open. The iShares U.S. Home Construction ETF climbed 3.5% to $108.74. D.R. Horton rose 2.8%, hitting $158.22, but Rocket Companies slid 1.7% to $20.00.

Mortgage News Daily’s rate index, covering top-tier conventional loans, held steady between 6.15% and 6.20% on Wednesday. Analyst Matthew Graham put it simply: “Flat bonds = flat rates.” Mortgage News Daily

Demand signals continue to fluctuate. The Mortgage Bankers Association reported an 8.9% decline in total mortgage applications last week, driven by a 14% plunge in purchase applications, as winter storm disruptions weighed on activity. “Winter Storm Fern likely had an impact…hampering homebuying activity,” said MBA economist Joel Kan. MBA

Federal Reserve Governor Lisa Cook took a cautious stance on policy Wednesday, saying it’s time to “wait and see” before cutting rates further. She called the current policy just “ever so mildly” restrictive. Reuters

Bond supply is a factor too. On Wednesday, the U.S. Treasury announced a $125 billion refunding plan and indicated it won’t raise note and bond auction sizes for several more quarters. That’s a key signal for markets since bigger issuance can weigh on bond prices and push yields higher. Reuters

Borrowers face a clear risk: if inflation concerns reignite, long-term yields could surge and lenders might tighten terms fast. January’s ISM index for prices paid in the U.S. services sector climbed, signaling that any easing in rates won’t be smooth. Reuters

Freddie Mac’s weekly survey, a key gauge of mortgage rates, will be released at noon (ET) on Thursday. It provides a more gradual snapshot of where typical mortgage offers stand. Freddie Mac

Investors are eyeing the U.S. jobs report for January, set for release on Feb. 11 at 8:30 a.m. (ET), searching for hints about economic growth and the Fed’s upcoming decisions — which will likely influence mortgage rates heading into next week. Bureau of Labor Statistics

Stock Market Today

  • Ultragenyx Pharmaceutical Shares Surge 8.1% Weekly Amid Valuation Debate
    April 9, 2026, 2:08 AM EDT. Ultragenyx Pharmaceutical (RARE) shares rose 8.1% last week to $23.15 amid mixed performance, down 1.9% year-to-date and 31.7% over 12 months. The biotech specializes in rare disease treatments, a sector sensitive to clinical trial and regulatory updates. Despite recent gains, the company's long-term returns remain negative. A discounted cash flow (DCF) analysis values Ultragenyx at about $257.43 per share, suggesting it is 91% undervalued based on future free cash flow projections turning positive by 2026. However, actual cash flow remains negative at $501.5 million last year. Investors must weigh DCF optimism against market risks and sector volatility. Ultragenyx scores 4 out of 6 in valuation, indicating some appeal but highlighting areas needing scrutiny.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 09.04.2026

9 April 2026
LIVEMarkets rolling coverageStarted: April 9, 2026, 12:00 AM EDTUpdated: April 9, 2026, 2:14 AM EDT Ultragenyx Pharmaceutical Shares Surge 8.1% Weekly Amid Valuation Debate April 9, 2026, 2:08 AM EDT. Ultragenyx Pharmaceutical (RARE) shares rose 8.1% last week to $23.15 amid mixed performance, down 1.9% year-to-date and 31.7% over 12 months. The biotech specializes in rare disease treatments, a sector sensitive to clinical trial and regulatory updates. Despite recent gains, the company's long-term returns remain negative. A discounted cash flow (DCF) analysis values Ultragenyx at about $257.43 per share, suggesting it is 91% undervalued based on future free cash flow
Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

8 April 2026
IREN shares rose 1.8% to $35.74 Wednesday as investors assessed its $6 billion share program and shift from bitcoin mining to AI cloud services. The company’s revenue fell to $184.7 million last quarter, with a net loss of $155.4 million. IREN recently announced a five-year, $9.7 billion AI cloud deal with Microsoft. Options trading volume hit 103,000 contracts Tuesday, with sentiment described as mixed.
Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

8 April 2026
Amazon closed at $213.77 Tuesday, with BNP Paribas maintaining a $320 price target, citing strong AI demand despite Amazon’s planned $200 billion capex for 2026. The company’s February forecast of higher spending sent shares down 11.5% after hours, even as AWS revenue rose 24% to $35.6 billion in the December quarter. Alphabet and Microsoft are also ramping up AI infrastructure spending.
Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

8 April 2026
The Sensex surged 2,946 points to 77,562.90 on Wednesday, its best day in five years, as a U.S.-Iran ceasefire and steady RBI rates pushed Indian markets higher. Brent crude fell 14.4% to $93.49 a barrel, easing pressure on the rupee, which rose 0.5% to 92.58 per dollar. All 16 major sectors gained, led by financials and auto stocks. The RBI kept its repo rate at 5.25% and forecast slower growth ahead.
Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

8 April 2026
Stock Yards Bank & Trust Co. increased its Netflix stake by 1,141.9% to 29,074 shares in Q4, while Ethos Capital Management disclosed a new 19,610-share position worth $1.84 million. The moves come ahead of Netflix’s April 16 earnings report and follow a Goldman Sachs upgrade to Buy with a $120 target. Insiders Reed Hastings and Greg Peters sold shares earlier this year under preset trading plans. Netflix last traded at $98.82.
AMD’s plunge, Nvidia’s China chip talks and Alphabet’s AI spend plan: what’s driving AI stocks today
Previous Story

AMD’s plunge, Nvidia’s China chip talks and Alphabet’s AI spend plan: what’s driving AI stocks today

XRP price dives 14% to $1.36 as bitcoin tests $70,000 — what traders watch next
Next Story

XRP price dives 14% to $1.36 as bitcoin tests $70,000 — what traders watch next

Go toTop